You are here: Industry Insights > COVID-19 vaccine development

News List

QPS Supports COVID-19 Vaccine Development In Taiwan, China prnewswire
August 02, 2021
QPS, a global contract research organization (CRO) focused on bioanalytics and clinical trials, is honored to have collaborated with Medigen Vaccine Biologics Corporation to complete toxicology studies necessary for the development of a COVID-19 vaccine.
NRx and Israel partner to advance Covid-19 vaccine development pharmaceutical-technology
July 13, 2021
NRx Pharmaceuticals has entered a memorandum of understanding with the Government of Israel to licence exclusive global development, manufacturing and commercialisation rights to a Covid-19 vaccine, BriLife.
Soligenix Announces $1.5 Million NIH Small Business Innovation Research Award Advancing COVID-19 Vaccine Development prnewswire
December 29, 2020
Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced that the National Institute of Allergy and Infectious Diseases (NIAID) ...
COVAXX, Aurobindo sign Covid-19 vaccine development deal pharmaceutical-technology
December 29, 2020
US company COVAXX has signed an exclusive agreement with Indian company Aurobindo Pharma to expand global development and commercialisation of the former’s multitope peptide-based Covid-19 vaccine, UB-612, to India and the United Nations Children’s Fund.
Govt allots R&D grant of Rs 900 crores for COVID-19 vaccine development expresspharma
November 13, 2020
Nirmala Sitharaman, Finance Minister of India, announcing the details of the third stimulus package, informed that Rs 900 crores would be provided for Covid Suraksha Mission.
CEPI to fund Clover’s Covid-19 vaccine development pharmaceutical-technology
November 06, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) has extended its partnership to fund the development of Sichuan Clover Biopharmaceuticals’ protein-based S-Trimer Covid-19 vaccine candidate.
CSIR and Aurobindo Pharma to collaborate for COVID-19 vaccine development expresspharma
September 16, 2020
DBT is also supporting Aurobindo Pharma’s COVID-19 vaccine development through its wholly-owned US subsidiary Auro Vaccines, under the National Biopharma Mission.
Scancell receives funding for COVID-19 vaccine development pharmatimes
August 27, 2020
Scancell Holdings has secured funding of around £2 million from Innovate UK to initiate a Phase I clinical trial of an experimental SARS-CoV-2 vaccine.
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals begins clinical trials worldpharmanews
June 29, 2020
GSK's scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine has entered into human clinical trials.
EIB Provides BioNTech with Debt Financing for COVID-19 Vaccine Development, Manufacturing americanpharmaceuticalreview
June 23, 2020
The European Investment Bank (EIB) and BioNTech SE concluded a €100 million debt financing agreement to support the development of BNT162, the company’s COVID-19 vaccine program.